<SEC-DOCUMENT>0001571049-17-001170.txt : 20170209
<SEC-HEADER>0001571049-17-001170.hdr.sgml : 20170209
<ACCEPTANCE-DATETIME>20170209161512
ACCESSION NUMBER:		0001571049-17-001170
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170209
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170209
DATE AS OF CHANGE:		20170209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		17587742

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t1700082_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported):
February 9, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Applied DNA Sciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center">(State or other jurisdiction<BR>
        of incorporation)</P></TD>
    <TD STYLE="width: 36%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>001-36745</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>59-2262718</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices; zip
code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%; text-align: justify; font-size: 10pt"></TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%; text-align: justify; font-size: 10pt"></TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%; text-align: justify; font-size: 10pt"></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%; text-align: justify; font-size: 10pt"></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 96%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 2.02&nbsp;&nbsp;Results of Operations and Financial Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On February 9, 2017, Applied DNA Sciences, Inc. (&ldquo;Applied
DNA Sciences&rdquo; or the &ldquo;Company&rdquo;) issued a press release announcing its results of operations for the fiscal quarter
ended December 31, 2016. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The information furnished pursuant to this Item 2.02, including
Exhibit 99.1, shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated
by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly
set forth by specific reference in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01.&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(<I>d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Applied DNA Sciences, Inc. dated February 9, 2017 regarding results of operations for the fiscal quarter ended December 31, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 9, 2017</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%"></TD>
    <TD STYLE="width: 7%"></TD>
    <TD STYLE="width: 42%"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 2%"></TD>
    <TD STYLE="width: 87%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by Applied DNA Sciences, Inc. dated February 9, 2017 regarding results of operations for the fiscal quarter&nbsp;&nbsp;ended December 31, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>t1700082_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><IMG SRC="t1700082_ex99-1logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Applied DNA Sciences Reports<BR>
Fiscal First Quarter 2017 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><I>Company to
Hold Conference Call and Webcast Today at 4:30 PM Eastern Time</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>STONY
BROOK, N.Y., February 9, 2017 - </B>Applied DNA Sciences, Inc. (NASDAQ: APDN) (&ldquo;Applied DNA&rdquo;, or &quot;the Company&quot;),
a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication
solutions, announced financial results for the fiscal 2017 first quarter ended December 31, 2016</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;Our fiscal first quarter results reflect variability in the
recognition of our deferred cotton revenue due to the timing of commitments in our textile business that masks an expansion in
our base of business over the prior quarter,&rdquo; stated Dr. James Hayward, president and CEO of Applied DNA. &ldquo;During the
quarter, we shipped SigNature T to mark a new premium cotton varietal and subsequent to quarter end, on-boarded a seventh U.S.
gin. We expect commitments for marked cotton utilizing taggant shipped during the fourth fiscal quarter of 2016 to allow for the
release of more deferred revenues in the current quarter as well as the remainder of fiscal 2017. We also began to mark synthetic
fiber with Techmer for use in the automotive industry and initiated a pilot project in an adjacent market that addresses the issues
of dilution and diversion in the fertilizer industry&rsquo;s supply chain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>First Quarter Financial Highlights:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues decreased 32% for the first quarter of fiscal 2017 to $903
thousand, compared with $1.32 million reported in the first quarter of fiscal 2016, and decreased 45% from the $1.64 million reported
in the fourth fiscal quarter ended September 30, 2016. The year-over-year decrease in revenue is primarily attributable to a decrease
in two government contract awards which both expired last quarter.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses were $4.6 million, compared with $4.1 million
in the prior year&rsquo;s quarter, an increase of approximately $460 thousand or 11%. The increase in year-over-year total operating
expenses is primarily attributable to an increase in SG&amp;A primarily associated with stock option grants offset by decreases
in legal and accounting fees, R&amp;D expenses and decreased amortization and depreciation. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for the quarter ended December 31, 2016 was $4.0 million,
or $0.16 per share, compared with a net loss of $2.9 million, or $0.13 per share for the quarter ended December 31, 2015 and a
net loss of $2.4 million, or $0.10 per share for the quarter ended September 30, 2016.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Excluding non-cash expenses, Adjusted EBITDA for the quarter ended
December 31, 2016 was negative $2.3 million compared to a negative Adjusted EBITDA of $2.2 million for the same quarter last year
and a negative Adjusted EBITDA of $1.7 million in the prior fiscal quarter due mainly to a decrease in revenues. See below for
information regarding non-GAAP measures.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash equivalents as of December 31, 2016 totaled $6.7 million
as compared to $4.5 million at September 30, 2016. The increase in cash balances is due primarily to a private placement completed
last November 2016 which netted $4.3 million.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in operating activities in the fiscal first quarter
of 2017 was $2.1 million. This compares with $2.7 million the corresponding prior-year period. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;We made steady progress in the quarter to expand our penetration
of business verticals with near-term drivers of growth while building our recurring revenue stream,&rdquo; continued Dr. Hayward.
&ldquo;In the most visible sign of market adoption of SigNature T DNA to date, through one of our partners, we will provide SigNature
T DNA to a prominent North American retailer over a multi-year period. This agreement represents the maturing of our cotton business,
giving us for the first time revenue certainty on an annual basis beginning with the 2017 ginning season. In our asset marking
vertical, the largest auto insurance company in Scandinavia has begun to actively promote our SmartDNA<FONT STYLE="color: #222222; background-color: white"><SUP>&reg;</SUP></FONT>
marking kit to policy holders of a second auto brand. Growing market adoption by these and other key business verticals, we believe,
sets the stage for greater and more diversified revenue opportunities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>Operational Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On January 24, 2017, the Company appointed Former New York Police
Department and current K2Intelligence Vice-Chairman Ray Kelly to its Strategic Advisory Board (SAB). At K2Intelligence, Mr. Kelly
provides valuable insight into the design and development of tailored enterprise risk solutions and investigates internal and external
risks affecting the safety of client assets and the reputation and stability of their key stakeholders.&nbsp;Mr. Kelly&rsquo;s
deep experience in security and law enforcement will help to guide Applied DNA&rsquo;s efforts in further penetrating its Home
Asset Valuables Marking and Cash and Valuable in Transit business verticals. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On
                                         January 18, 2017, Applied DNA announced the results of a cotton survey conducted by Harris
                                         Poll that indicated that consumer buying decisions are increasingly linked to authentic
                                         practices promised by brands. The survey shows that 78% of Americans would likely buy
                                         brands that showed scientific proof of product claims (100% organic, 100% Pima cotton,
                                         etc.) over ones that did not. The findings validate the value proposition of SigNature
                                         T DNA mark to eliminate concerns over origin, diversion, any mislabeling, and any counterfeiting
                                         that can take place throughout the cotton supply chain. <U>For additional information
                                         on the cotton survey, please click here</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On January 4, 2017, the Company appointed PepsiCo Vice Chairman and
Chief Scientific Officer of Global Research and Development Dr. Mehmood Khan to its SAB. Dr. Khan&rsquo;s decades of involvement
in the global food, beverage and pharmaceutical industries, as well as his depth of scientific innovation experience, are well
suited to complement Applied DNA&rsquo;s penetration of its new vertical markets.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On December 14, 2016, Applied DNA announced that it will provide its
SigNature T DNA products and services platform to empower textile supply chain security for one of the largest U.S.-based retailers
over an extended multi-year period with established revenue thresholds.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On December 7, 2016, the Company announced that revenues from the
DNA marking of European luxury automobiles are expected to increase in fiscal 2017 from approximately $500,000 in fiscal 2016.
Applied DNA attributes the expected increase to the promotion of its SmartDNA<FONT STYLE="color: #222222; background-color: white"><SUP>&reg;</SUP></FONT>
product by a Scandinavian car manufacturer to its more than one million customers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Concluded Dr. Hayward, &ldquo;As growing
market awareness converts into adoption, the value proposition of SigNature T DNA has attracted individuals to the Company whose
cumulative industry expertise and business acumen can help shape our growth and open new avenues for business development. Dr.
Mehmood Khan, vice-chairman of PepsiCo, and Ray Kelly, former Commissioner of the New York Police Department, will add valuable
insight into our business strategy as we build our base of business across key verticals. Together with the opportunities ahead
of us and the financial resources with which to pursue them, we believe Applied DNA Sciences is well positioned to succeed.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Fiscal 2017 First Quarter Conference Call Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company will hold a conference call and webcast to discuss its
fiscal 2017 first quarter results on Thursday February 9, 2017 at 4:30 PM EST.To participate on the conference call, please follow
the instructions below. While every attempt will be made to answer investors&rsquo; questions on the Q&amp;A portion of the call,
due to the large number of expected participants, not all questions may be answered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>To Participate: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll Free: 1-844-887-9402</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll: 1-412-317-6798</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Please ask to be joined to the Applied DNA Sciences earnings call</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Live webcast: <U>http://services.choruscall.com/links/apdn170209.html</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Replay (available 1 hour following the conclusion of the live
call): </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll Free: 1-877-344-7529</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll: 1-412-317-0088</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Passcode: 10098826</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Webcast
                                         replay: <U>https://services.choruscall.com/ccforms/replay.html</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Information about Non-GAAP Financial Measures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As used herein, &ldquo;GAAP&rdquo; refers to accounting principles
generally accepted in the United States of America. To supplement our condensed consolidated financial statements prepared and
presented in accordance with GAAP, this earnings release includes Adjusted EBITDA, which is a non-GAAP financial measure as defined
in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a
numerical measure of a company&rsquo;s historical or future performance, financial position, or cash flows that either excludes
or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented
in accordance with GAAP.The presentation of this non-GAAP financial information is not intended to be considered in isolation or
as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use this non-GAAP
financial measure for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons
of the performance and results of operations of our core business. Our management believes that these non-GAAP financial measures
provide meaningful supplemental information regarding the performance of our business by excluding non-cash expenses that may not
be indicative of our recurring operating results. We believe this non-GAAP financial measure is useful to investors as it allows
for greater transparency with respect to key metrics used by management in its financial and operational decision making.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;EBITDA&rdquo;- is defined as earnings (loss) before interest
expense, income tax expense and depreciation and amortization expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;Adjusted EBITDA&rdquo;- is defined as EBITDA adjusted to
exclude (i) stock-based compensation and (ii) other non-cash expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About Applied DNA Sciences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #222222"><IMG SRC="t1700082_ex99-1pg3.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #222222">We make life real and safe
by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire
supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability
and quality of products. SigNature<SUP>&reg;</SUP> DNA describes the platform ingredient that is at the heart of a family of uncopyable,
security and authentication solutions such as SigNature<SUP>&reg;</SUP> T and fiberTyping<SUP>&reg;</SUP>, targeted toward textiles
and apparel, DNAnet<SUP>&reg;</SUP>, for anti-theft and loss prevention, and digitalDNA<SUP>&reg;</SUP>, providing powerful track
and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale
production of specific DNA sequences using the polymerase chain reaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Go to <B>adnas.com </B>for more information, events and to learn
more about how Applied DNA Sciences makes life real and safe.&nbsp;Our common stock is listed on NASDAQ under the symbol APDN,
and our publicly traded warrants are listed on NASDAQ under the symbol APDNW.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The statements made by APDN&nbsp;in this press release&nbsp;may
be&nbsp;&ldquo;forward-looking&rdquo;&nbsp;in nature&nbsp;within the meaning of the Private Securities Litigation Act of 1995.&nbsp;Forward-looking
statements describe APDN&rsquo;s future plans, projections, strategies and expectations, and are based on assumptions and involve
a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from
those projected due to our short operating history, limited financial resources, limited market acceptance, market competition
and various other factors detailed from time to time in APDN&rsquo;s SEC reports and filings, including our Annual Report on Form
10-K filed on&nbsp;December 6, 2016, which is available at&nbsp;www.sec.gov. APDN undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence
of unanticipated events, unless otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: Red"><IMG SRC="t1700082_ex99-1logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Investor contact:</B>Debbie Bailey, 631-240-8817, <B>debbie.bailey@adnas.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Sanjay M. Hurry, 212-838-3777, LHA, <B>shurry@lhai.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Media contact: </B>Susan Forman, Dian Griesel Int&rsquo;l., 212-825-3210,<B>sforman@dgicomm.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>web:</B> www.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>twitter: </B>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Financial Tables Follow</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CONDENSED CONSOLIDATED BALANCESHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">December 31,</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">September 30,</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(unaudited)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 74%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">6,701,586</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">4,479,274</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts receivable, net of allowance of $23,411 and&nbsp;&nbsp;$32,965 at December 31, 2016 and September 30, 2016, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,156,173</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,374,895</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">323,324</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297,759</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">133,230</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">200,006</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,314,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,351,934</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Property, plant and equipment-net of accumulated depreciation of $1,363,789 and $1,263,200 at December 31, 2016 and September 30, 2016, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">723,790</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">792,499</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Other assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long term accounts receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">920,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,535,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,626</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,126</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,986</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Intangible assets, net of accumulated amortization of $485,037 and $423,649, as of December 31, 2016 and September 30, 2016, respectively</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,464,512</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,525,900</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">16,769,627</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,565,831</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,201,021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,247,341</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,791,707</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,837,588</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,992,728</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,084,929</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">&nbsp;Long term accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">127,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">215,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Long term deferred revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">468,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">900,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,587,728</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,200,429</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stockholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2016 and September 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Series A Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of as of December 31, 2016 and September 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Series B Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of December 31, 2016 and September 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Common stock, par value $0.001 per share; 500,000,000 shares authorized; 26,351,483 and 24,078,756 shares issued and outstanding as of December 31, 2016 and September 30, 2016, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,351</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,079</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">239,934,320</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,158,711</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(227,778,772</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(223,817,388</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,181,899</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,365,402</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Liabilities and Stockholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">16,769,627</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,565,831</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">Three Months Ended <BR>December 31,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Revenues:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left">Product revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">704,417</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">693,214</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Service revenues</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">198,591</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">630,900</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Total revenues</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">903,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,324,114</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cost of revenues</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">274,832</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">184,268</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,900,917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,169,063</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">518,628</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">672,965</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">161,977</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">218,346</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,581,522</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,060,374</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">LOSS FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,953,346</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,920,528</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest income (expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,331</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,845</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other income (expense),&nbsp;net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(9,369</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,587</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,961,384</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,926,270</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">NET LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,961,384</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,926,270</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share-basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.16</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.13</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average shares outstanding- Basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">25,427,407</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">22,542,176</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CALCULATION AND RECONCILIATION OF ADJUSTED
EBITDA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="text-align: center">Three Months Ended December 31,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 74%; text-align: left">Net Loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(3,961,384</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(2,926,270</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Interest (income) expense, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,331</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,845</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,977</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">218,346</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Stock based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,458,020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">455,111</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Bad debt expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,646</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,624,312</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">680,612</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,337,072</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,245,658</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>t1700082_ex99-1pg3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 t1700082_ex99-1pg3.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ M "U P$1  (1 0,1 ?_$ -    $$ @,! 0
M       &!P@)!0H! P0""P$!   ' 0$               (#! 4&!P@!"1
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M>BT\H.NNJ0X,<!,3'B)B8\N,1A^I9_3::;4WE,D3E[H!'_;KJ<X]6*RJ6O\
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MW*S,HX180L$V$0.Z>'\SR4@$0(<=BCQ!;*2FJG5,(<%.A$RI2R2)C@)ZC,\
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M4DGBDF>' ^,0[F[(6ZR6=R^[<>^<M[0)4H<)>P3]D,;[>7M:VOF]6;1E.R9
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M$23*/Y"I@ :^J&U["SMG;S%J; 3II2)>B8^<VX+P[?+T]7*,TFI&/^M%QO\
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MZQT$PHNTSKJ/CF3%HWL_<DE^._-7'Z3^0%M3<P &*;<B<PE;"O.* -9D#AU
M#QTZFF)!$/\ KJ /0=:3^I#:*-U['J+W3IUW6F+:A+XM(//Y_"3&W^P^\EVG
M=++5:K32K"T'PFH23]L;=G*+'<G;\CXOFK-BV;SMB")BY5N_QM$2T4BSBKX[
MDXP\3=K15YF3B(VYQ#2**N@1%118&:HBH5 XF 2_.ZPKI^B\TAU#-4DGF.9
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MQS++K++K'V RRRJBRI@*!B@!E%3'.(%*80#KT =5+-!:[<]_REL,V^0TID
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MTD^W"/1[*-E=(^VA9'=9*V?62E6S,:Z$8HGYQ%IMK')SD0U=-TS%452>'42
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MPQ0#NB(+)\4T:ED7!.U)45! QAZZN] &Z,"GL"/FJQM/49;(UBKH5@%ZE7+
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M%!]G^TR')KD<^5V**BPQ^/6K%DLIO^F#DA##]0!K-*R[';Y5-?4I6ENE*)S
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MQ."5*02I!(4I)!(P)!S!\0>(R,=BYE''8#E55UY8[D]0JHX @[!U)YIC 7H
M>'RU3,6RVTQU4U.PVJ<YH;0G'QP Q\\XG.U54^)/.N+$@.92C@!(#$G # #(
M" .AMO Q WVZ@)2#\OB!?ZM5M.FX:NM4DE200DJQ(2<9 G$#C(812U3M%@&#
MS> _R0O<8XJR-FBYQ6/<4T^;O-PFG!$&D'7VAUW6RI@(+MTY*7TT8R;=W>JN
MN<B12 /</PU8;QN;:NW*9RX[G?;;;0@AJ9 FL<VG$C"4S+'TBZ6NQ7?<3[=%
M:&2M\*!493(3E/(\8W"O;2]HBI<5%8K+^=T82\Y_6;I+1+%(OK:GC$5$BF43
M@BK]B4G/[CLM(&3W2$>U$ +N?7S^[M_4!N#>SYL-N4XSMV9')RZQYZ0,/$9Q
MVYVR[1,;>81<[\E*ZJ0,E"<O:?\ -%G.<N0*6!9K'\C=JL^#"]HD3UJYY;C'
MA5V&*+&\70)5'5XA_(%5I2)Y=46RLN!A18+F3]0!4E/,+SZ4)&&8'CG&^>3_
M '7\+AZ16S[A5'23R8^LN3*+#6#$&<H7'U%J?)Z5/)RL=PU=12CX9ZP RAG)
M'\$I:R.4W<+8&O8@G,&(#Y8K5,A3^C 2&4>2$Y\8L&XF9=7R,AE2N1DW&WS'
M.*;36Z-C'+L;*.YU#)$ A2X)=ZZEK$XW;V.UP<R9="5>M3"V6<F^G8P& $>Q
M(1(ZMKFO7@14U>KCH_VW<!\N7GDMTU'X$_,=E%?41$0'8ZQC#X &D(<$"AL
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,D(-(0:0@TA!I"/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>t1700082_ex99-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 t1700082_ex99-1logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *@$. P$1  (1 0,1 ?_$ +L   $#! ,!
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M#PB[.WK-@E\[UVU9HB8J8*NW"39(3G'HI 46.0GN-^ =]CPBN0$# !BB!BF
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MG;=9G==[80W#OEM$)D!)X 4E'V:)Z!]F,;G*)?\ [W-G2=@/YB:T2(& 1*8
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,O"(X1'"(X1'"+__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
